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— and it is particularly irrespon-
sible when the interventions are 
provided at public expense. On 
the other hand, we must avoid 
an innovation policy that cuts off 
new interventions prematurely. 
Some interventions that are not 
cost-effective at first may prove 
to be so over time and with 
greater experience in implement-
ing them. It is in gathering this 
experience that the private part 
of the “should” question becomes 
important. Given a substantial 
market for untried, cutting-edge 
interventions that are not subsi-
dized by the public purse, some 
innovations may prove to be cost-
effective in the long run. Such 
innovations should then be in-
cluded in the publicly financed 
benefit package.
Disclosure forms provided by the author 
are available with the full text of this article 
at NEJM.org.
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AIDS in America — Forgotten but Not Gone
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Over the past decade, limited attention has been paid to 
the human immunodeficiency vi-
rus (HIV) epidemic in the United 
States. The global epidemic — 
particularly the epidemic in sub-
Saharan Africa, where approxi-
mately two thirds of the world’s 
population living with AIDS re-
sides — has rightfully received 
most of the focus. Meanwhile, 
however, the prevalence of HIV 
infection within some U.S. popu-
lations now rivals that in some 
sub-Saharan African countries 
(see graph). For example, more 
than 1 in 30 adults in Washing-
ton, D.C., are HIV-infected — a 
prevalence higher than that re-
ported in Ethiopia, Nigeria, or 
Rwanda.1 Certain U.S. subpopu-
lations are particularly hard hit. 
In New York City, 1 in 40 blacks, 
1 in 10 men who have sex with 
men, and 1 in 8 injection-drug 
users are HIV-infected, as are 1 in 
16 black men in Washington, 
D.C.2 In several U.S. urban areas, 
the HIV prevalence among men 
who have sex with men is as high 
as 30%3 — as compared with a 
general-population prevalence of 
7.8% in Kenya and 16.9% in South 
Africa.
During the first two decades 
of the epidemic, remarkable ad-
vances in preventing mother-to-
child transmission, screening of 
blood and blood products, and 
behavior change among men who 
have sex with men resulted in 
significant decreases in new HIV 
infections in the United States 
— from approximately 130,000 
in 1984 to about 60,000 in 1991. 
For the past decade, however, 
progress has been stalled. It had 
been anticipated that effective 
antiretroviral therapy, with its 
suppressive effect on viral repli-
cation, would reduce the overall 
rate of new infections, but this 
expectation has not been realized. 
More than half a million Ameri-
cans became infected with HIV 
in the past decade, including 
about 56,000 in the past year.4 It 
is estimated that there are now 
more than 1 million HIV-infected 
Americans, more than 20% of 
whom are unaware of their in-
fection.
Unlike the generalized HIV 
epidemics in sub-Saharan Africa, 
the U.S. epidemic primarily af-
fects certain discrete geographic 
areas — especially urban areas 
of the Northeast and West Coast 
and cities and small towns in 
the South (see U.S. map). Within 
these areas, specific neighbor-
hoods are often disproportionate-
ly affected (see New York City 
map), in part because of residents’ 
engagement in unprotected sex 
within relatively insular social–
sexual networks. Many of the 
populations most affected tend to 
have limited social mobility; thus, 
partner selection tends to concen-
trate transmission patterns and 
amplify spread within defined 
geographic areas.
Traditionally, researchers and 
policymakers concerned with HIV 
acquisition have concentrated on 
specific high-risk transmission 
behaviors, including injection-drug 
use, sex with multiple partners, 
and failure to use protective mea-
sures such as condoms or safe 
injection practices. It is now evi-
dent that among men who have 
sex with men, the use of drugs 
such as crystal methamphetamine 
— especially at sex parties and in 
venues such as bathhouses — 
has contributed to risky behavior 
and HIV acquisition. Other dis-
inhibiting substances, including 
alcohol and cocaine, are also as-
sociated with increased risk tak-
ing in these populations.
However, the extent of the risk 
of acquiring HIV in the United 
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States today is largely defined by 
a person’s sexual network rather 
than his or her individual behav-
iors. Understanding the context 
and settings in which risk is in-
creased may lead to more robust 
and effective preventive interven-
tions. For example, black men 
who have sex with men are at 
increased risk for HIV infection 
in part because of its high prev-
alence in their sexual networks 
and their likelihood of choosing 
racially similar partners; they have 
also been shown to be less likely 
than their white counterparts to 
be aware of their HIV status and 
thus are more likely to unknow-
ingly transmit HIV.5 Moreover, 
even those who are aware of their 
HIV infection may be less en-
gaged in HIV care and less likely 
to avail themselves of antiretro-
viral therapy — behavior that lim-
its the potential benefit of such 
therapy as a preventive strategy.
The situation is similar for 
black and Hispanic women, whose 
increased risk of HIV acquisition 
is attributable in greater part to 
their vulnerable social and eco-
nomic situations and their sexual 
networks than to their own risky 
behaviors. Socioeconomic disad-
vantage and instability of part-
nerships due to high rates of in-
carceration among men in their 
communities may lead women to 
engage in concurrent relation-
ships or serial monogamy. In ad-
dition, they may be unaware of 
their partners’ HIV status or may 
be involved in abusive or econom-
ically dependent relationships and 
thus be unable to negotiate safer 
sex with their partners.
The specific characteristics of 
the U.S. HIV epidemic — low 
prevalence in the general popu-
lation, high prevalence among the 
disenfranchised and socially mar-
ginalized, with a concentration in 
geographic hotspots — in combi-
nation with the various structural 
impediments to prevention create 
unique challenges for the design 
and implementation of effective 
interventions. Thus, a nuanced 
and targeted approach that avoids 
stigmatization of these popula-
tions is necessary. Structural in-
terventions might include tackling 
the disproportionate incarceration 
of black and Hispanic men, urging 
health insurers to reimburse pro-
viders for preventive care, and us-
ing microcredit to help women out 
of poverty so that they avoid the 
perceived need to engage in com-
mercial sex or other coercive sex.
Research tailored to specific 
populations is required if we are 
to gain the understanding needed 
to move forward. For example, 
how do we identify those people 
in the United States who are at 
greatest risk for HIV acquisition, 
especially among women? Al-
though more than a quarter of 
new HIV infections in the United 
States occur in women (predom-
inantly black or Hispanic women), 
identifying such at-risk women to 
engage them in prevention stud-
ies has proven particularly chal-
lenging. Research is also needed 
to identify interventions that will 
persuade men who have sex with 
men to undergo HIV testing, fa-
cilitate their disclosure of their 
HIV status to sexual partners, and 
promote negotiations for safer 
sexual practices; such interven-
tions need to be implemented in 
the settings where such men may 
meet (e.g., in bars or on the Inter-
net). Additional qualitative re-
search is needed to understand 
how the targeted community uses 
various sources of information 
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HIV Prevalence in Adults from Selected Countries in Sub-Saharan Africa and Subpopulations  
in the United States.
Data are from the Centers for Disease Control and Prevention, the District of Columbia Department 
of Health, the New Jersey Department of Health, the New York City Department of Health and 
Mental Hygiene, and the Joint United Nations Program on HIV/AIDS (UNAIDS). MSM denotes 
men who have sex with men.
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in making decisions about sexual 
risk taking.
Most glaringly, HIV dispropor-
tionately affects poor black Amer-
icans who have substandard edu-
cation, unstable housing, and 
limited social mobility. This con-
fluence of factors may result in 
high rates of incarceration, which 
threaten a community’s social fab-
ric. Such vulnerable populations 
must be engaged in research, pro-
gram development, and interven-
tions that are culturally relevant 
and address the socioeconomic 
milieu in which HIV transmis-
sion occurs.
Preventive interventions must 
be rooted in science, not driven 
by ideological concerns. Homo-
phobia may have impeded the 
development of sexually appro-
priate prevention studies among 
men who have sex with men. Re-
luctance to fund studies of needle 
exchange or conditional cash 
transfer (providing financial in-
centives for healthy behavior) or 
to support work in high-risk 
venues, such as bathhouses, has 
hampered progress. Cash trans-
fer has proved effective in achiev-
ing desirable health outcomes, 
including weight control, smok-
ing cessation, and decreased use 
of crystal methamphetamine, but 
until recently it was not being 
studied for use in HIV prevention 
in the United States.
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Neighborhoods in New York City
Numbers of Reported AIDS Cases According to Metropolitan Statistical Area of Residence, Cumulative through 2007.
Only metropolitan statistical areas with a population of more than 500,000 were included. Data are from the HIV/AIDS Surveillance Report, 
2007, Centers for Disease Control and Prevention. The inset shows the proportion of persons living with HIV–AIDS in New York City. 
Data are from the New York City Department of Health and Mental Hygiene, Epidemiology and Field Services Program, October 2009.
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What will it take to control 
the U.S. HIV epidemic? First, there 
is an urgent need to acknowl-
edge that HIV remains a major 
health threat in the United States. 
Second, concerted effort and sub-
stantial resource investment — 
especially in innovative and cou-
rageous approaches — are 
necessary. Focused studies of the 
sociocultural dynamics that facil-
itate transmission are needed, as 
well as large studies assessing the 
effectiveness of multidimensional 
interventions, including behav-
ioral, biomedical, and structural 
components. Disenfranchised com-
munities must be engaged as 
partners in such efforts, along 
with new researchers drawn from 
the affected populations, if the 
nuances of local epidemics are to 
be addressed. The time has come 
to confront this largely forgotten 
and hidden epidemic.
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Five Next Steps for a New National Program  
for Comparative-Effectiveness Research
Jordan M. VanLare, A.B., Patrick H. Conway, M.D., and Harold C. Sox, M.D.
The American Recovery and Reinvestment Act appropri-
ated $1.1 billion to fund compar-
ative-effectiveness research (CER) 
— unprecedented generosity for 
a program for evaluating health 
care practices. The legislation 
established the Federal Coordinat-
ing Council for Comparative Ef-
fectiveness Research and charged 
it with advising the secretary of 
health and human services on the 
allocation of CER funds. It also 
mandated an Institute of Medi-
cine (IOM) study to recommend 
initial national priorities for CER. 
Both the Federal Coordinating 
Council and the IOM reported to 
Congress on June 30, 2009.
Both organizations solicited in-
put from stakeholders. The IOM 
committee issued an open solici-
tation asking the public to nomi-
nate research topics. It received 
1546 nominations, which it nar-
rowed to 100 highest-priority re-
search questions. The Federal Co-
ordinating Council hosted three 
public listening sessions to iden-
tify priorities and posted drafts 
of its work on its Web site for 
public comment. By establishing 
a national CER agenda with input 
and support from diverse stake-
holders, the two reports moved 
the United States closer to creat-
ing a sustained national CER pro-
gram.1,2
Both reports recognized the 
need for a robust CER enterprise. 
The IOM made 10 recommenda-
tions for its development (see box). 
The Federal Coordinating Coun-
cil’s report included a definition 
of CER, a strategic framework, 
priority-setting criteria, and rec-
ommendations for investing the 
$400 million that Congress allo-
cated to the Department of Health 
and Human Services for CER. 
Both reports recommended creat-
ing CER data networks and con-
ducting research on practitioners’ 
adoption of changes based on 
CER findings.3
Federal agencies and Congress 
appear willing to implement these 
recommendations. The National 
Institutes of Health, the Agency 
for Healthcare Research and Qual-
ity (AHRQ), and the secretary of 
health and human services have 
begun to allocate their Recovery 
Act funds and coordinate their ef-
forts. The AHRQ has requested 
proposals for studying the IOM’s 
high-priority research questions 
that fit within its own priori-
ties,4 and the secretary of health 
The New England Journal of Medicine 
Downloaded from nejm.org at COLUMBIA UNIV HEALTH SCIENCES LIB on October 13, 2015. For personal use only. No other uses without permission. 
 Copyright © 2010 Massachusetts Medical Society. All rights reserved. 
